Recursion Pharmaceuticals (NASDAQ:RXRX) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS
Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.05), Briefing.com reports. The firm had revenue of $14.42 million for the quarter, compared to analysts’ expectations of $11.96 million. Recursion Pharmaceuticals had […]
More Stories
Pending Home Sales Plunge to Record Low as Mortgage Rates Surge: NAR
By Bill Pan A new report adds to the evidence that rising borrowing costs are weighing heavily on housing demand,...
NY, Feds Raid Programs Suspected of Fraud in New York City
By Zachary Stieber The FBI and state officials launched an operation in New York City on Oct. 20 to crack...
Amazon to Hire 300,000 US Workers for Holiday Season
By Andrew Moran Amazon has posted a help-wanted sign for this year’s holiday season. The online retailer said on Oct....
Trump Launches $25 Million Fraud Whistleblower Program, Offering Cash for Tips
By Emel Akan WASHINGTON—President Donald Trump and Vice President JD Vance announced on Tuesday the launch of a $25 million...
US, Partners Seize Nearly 1,500 Pounds of Cocaine in the Caribbean
By Naveen Athrappully A U.S. task force and foreign partners seized nearly 1,500 pounds of cocaine in two operations in...
European Union Unveils Arctic Strategy Aimed at Strengthening Security
By Victoria Friedman The European Union (EU) has unveiled plans to boost security in the Arctic that include better threat...